Storia in 20 fonti

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA approves Revolution Medicines' daraxonrasib (Rasonque) for second-line pancreatic cancer, after it nearly doubled survival in a Phase 3 to 13.2 months vs. 6.7 months on chemo.

Raccontata da

lasicilia.it+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo11 h fa

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA approves Revolution Medicines' daraxonrasib (Rasonque) for second-line pancreatic cancer, after it nearly doubled survival in a Phase 3 to 13.2 months vs. 6.7 months on chemo.

originale

Timeline cronologica

mercoledì 26 agosto 2026·forbes.com
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque
Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.
mercoledì 26 agosto 2026·biopharmadive.com
Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly…

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

Confronto fonti

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

Timeline cronologica

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

FDA approves ‘game-changing’ pancreatic cancer drug

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA greenlights Revolution Medicines' pancreatic cancer gamechanger

FDA approves breakthrough drug to treat advanced pancreatic cancer

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

Tumore del pancreas, via libera negli Usa alla prima terapia mirata contro il gene killer RAS

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | The Jerusalem Post

New hope for pancreatic cancer patients after FDA approves drug to improve survival

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

FDA approves new treatment for those with advanced pancreatic cancer - UPI.com

FDA Approves Landmark Pancreatic Cancer Drug That's Shown To Improve Survival

FDA approves breakthrough pancreatic cancer drug proven to extend survival